20 Years of Basic Research in Homeopathy – Research Meeting at Hevert-Arzneimittel

On Thursday 25 October 2016, Hevert-Arzneimittel hosted a one day conference on basic research in homeopathy Nussbaum, Germany at Hevert-Arzneimittel headquarters. Dr. Stephan Baumgartner, private lecturer at the University of Witten/Herdecke, Dr. Tim Jäger from the University of Bern, and Sandra Würtenberger, member of the research team and Hevert employee, presented an overview over 20 years of basic research, current studies and future trends.

Presented an overview of the current state of basic research in homeopathy: (from left) Managing Director of Hevert-Arzneimittel Marcus Hevert, PD Dr. Stephan Baumgartner, Sandra Würtenberger and Dr. Tim Jäger.

“There are several high-quality studies as well as many open issues,” Baumgartner explained to guests from associations, manufacturers and practitioners. This is what makes this research area so interesting for us.” The researchers presented an overview of more than 20 years of research in homeopathy as well as current work on a review of physical tests of homeopathic potencies and studies on homeopathic preparations using damaged duckweed. “20 years in an area like this with a rudimentary research infrastructure is not much. Results need time,” said Baumgartner who is one of the most important homeopathic researchers in Germany.

The potential mechanisms of action for potentization and the law of similars are not well understood and remain controversial. The procedure for potentization, for example, has been regulated by law for years but from the scientific point of view the ratio used for this procedure needs yet to be validated. The objective of the joint research projects is the establishment of a working group for basic research on the topic of homeopathic potentization. Basic research in homeopathy examines whether homeopathic preparations show specific effects that cannot be explained by a placebo effect.

Evidence on a cellular level exists for homeopathy including duckweed experiments, the frog-metamorphosis model, biocrystallization or NMR relaxation measurements, empiric evidence for specific effects of homeopathically potentized preparations. “What is missing is a theory explaining the effect. This is what further research needs to focus on.”

“We think that in the next few years the task of homeopathy research is to make existing proof of efficacy explicable by using appropriate theories. Unfortunately, public funds are limited for the support of research in this area which is why the progress is slower than in other research areas,” explains Mathias Hevert, Managing Director of Hevert-Arzneimittel. “As a pharmaceutical manufacturer we are firmly rooted in homeopathy. Therefore creating a scientific basis for this therapy approach naturally matters to us”, adds Co-Managing Director Marcus Hevert. As a family business in close touch with nature, Hevert-Arzneimittel has been actively committed to naturopathy and homeopathy for decades.

This one day conference is an important step for Hevert-Arzneimittel’s initiatives in basic research in homeopathy.

Further information:
Homeopathy research